Hepatic insulin sensitivity is improved in high‐fat diet‐fed Park2 knockout mice in association with increased hepatic AMPK activation and reduced steatosis

por Edmunds, Lia R., Huckestein, Brydie R., Kahn, Mario, Zhang, Dongyan, Chu, Yanxia, Zhang, Yingze, Wendell, Stacy G., Shulman, Gerald I., Jurczak, Michael J.
Publicado en Physiol Rep (2019)

Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance

por Edmunds, Lia R., Xie, Bingxian, Mills, Amanda M., Huckestein, Brydie R., Undamatla, Ramya, Murali, Anjana, Pangburn, Martha M., Martin, James, Sipula, Ian, Kaufman, Brett A., Scott, Iain, Jurczak, Michael J.
Publicado en Mol Metab (2020)

Adropin reduces blood glucose levels in mice by limiting hepatic glucose production

por Thapa, Dharendra, Xie, Bingxian, Manning, Janet R., Zhang, Manling, Stoner, Michael W., Huckestein, Brydie R., Edmunds, Lia R., Zhang, Xueyang, Dedousis, Nikolaos L., O'Doherty, Robert M., Jurczak, Michael J., Scott, Iain
Publicado en Physiol Rep (2019)

Adropin treatment restores cardiac glucose oxidation in pre-diabetic obese mice

por Thapa, Dharendra, Xie, Bingxian, Zhang, Manling, Stoner, Michael W., Manning, Janet R., Huckestein, Brydie R., Edmunds, Lia R., Mullett, Steven J., McTiernan, Charles F., Wendell, Stacy G., Jurczak, Michael J., Scott, Iain
Publicado en J Mol Cell Cardiol (2019)

Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice

por Costa, Diana K., Huckestein, Brydie R., Edmunds, Lia R., Petersen, Max C., Nasiri, Ali, Butrico, Gina M., Abulizi, Abudukadier, Harmon, Daniel B., Lu, Canying, Mantell, Benjamin S., Hartman, Douglas J., Camporez, João-Paulo G., O'Doherty, Robert M., Cline, Gary W., Shulman, Gerald I., Jurczak, Michael J.
Publicado en Am J Physiol Endocrinol Metab (2016)

Hepatocyte-Specific Ablation or Whole-Body Inhibition of Xanthine Oxidoreductase in Mice Corrects Obesity-Induced Systemic Hyperuricemia Without Improving Metabolic Abnormalities

por Harmon, Daniel B., Mandler, W. Kyle, Sipula, Ian J., Dedousis, Nikolaos, Lewis, Sara E., Eckels, Jeremy T., Du, Jianhai, Wang, Yekai, Huckestein, Brydie R., Pagano, Patrick J., Cifuentes-Pagano, Eugenia, Homanics, Gregg E., Van’t Erve, Thomas J., Stefanovic-Racic, Maja, Jurczak, Michael J., O’Doherty, Robert M., Kelley, Eric E.
Publicado en Diabetes (2019)